Paper20041971
FXR an emerging therapeutic target for the treatment of atherosclerosis.
Mencarelli A and 1 other. J Cell Mol Med, 2010. Cited by 78 papers, by iCite.
Cite this record
ConductScience Library. FXR an emerging therapeutic target for the treatment of atherosclerosis. Papers, record 20041971. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20041971
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Atherosclerosis | Major topic |
| Receptors, Cytoplasmic and Nuclear | Major topic |
| Animals | |
| Bile Acids and Salts | |
| Cholesterol | |
| Glucose | |
| Humans | |
| Insulin | |
| Liver | |
| Models, Molecular | |
| Protein Structure, Tertiary | |
| Signal Transduction | |
| Triglycerides | |
| Receptor, Farnesoid X-Activated |
Source PubMed
References112
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14664901 | The DDAH/ADMA/NOS pathway. | Atheroscler Suppl | 2003 | https://conductscience.org/library/papers/14664901 | PubMed |
| 2 | 19418582 | Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation. | World J Gastroenterol | 2009 | https://conductscience.org/library/papers/19418582 | PubMed |
| 3 | 19174369 | Activation of farnesoid X receptor prevents atherosclerotic lesion formation in LDLR-/- and apoE-/- mice. | J Lipid Res | 2009 | https://conductscience.org/library/papers/19174369 | PubMed |
| 4 | 12093894 | Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. | J Clin Invest | 2002 | https://conductscience.org/library/papers/12093894 | PubMed |
| 5 | 15337761 | Bile acid reduces the secretion of very low density lipoprotein by repressing microsomal triglyceride transfer protein gene expression mediated by hepatocyte nuclear factor-4. | J Biol Chem | 2004 | https://conductscience.org/library/papers/15337761 | PubMed |
| 6 | 12062084 | Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis. | Dev Cell | 2002 | https://conductscience.org/library/papers/12062084 | PubMed |
| 7 | 17065154 | Farnesoid X receptor agonist reduces serum asymmetric dimethylarginine levels through hepatic dimethylarginine dimethylaminohydrolase-1 gene regulation. | J Biol Chem | 2006 | https://conductscience.org/library/papers/17065154 | PubMed |
| 8 | 17110163 | Effects of FXR in foam-cell formation and atherosclerosis development. | Biochim Biophys Acta | 2006 | https://conductscience.org/library/papers/17110163 | PubMed |
| 9 | 16778009 | The farnesoid X receptor promotes adipocyte differentiation and regulates adipose cell function in vivo. | Mol Pharmacol | 2006 | https://conductscience.org/library/papers/16778009 | PubMed |
| 10 | 12524422 | A G protein-coupled receptor responsive to bile acids. | J Biol Chem | 2003 | https://conductscience.org/library/papers/12524422 | PubMed |
| 11 | 17179929 | Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes. | Nat Clin Pract Endocrinol Metab | 2007 | https://conductscience.org/library/papers/17179929 | PubMed |
| 12 | 17720959 | Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine. | J Lipid Res | 2007 | https://conductscience.org/library/papers/17720959 | PubMed |
| 13 | 17895379 | Involvement of corepressor complex subunit GPS2 in transcriptional pathways governing human bile acid biosynthesis. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/17895379 | PubMed |
| 14 | 18249172 | Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. | Cell Metab | 2008 | https://conductscience.org/library/papers/18249172 | PubMed |
| 15 | 16446356 | The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice. | J Biol Chem | 2006 | https://conductscience.org/library/papers/16446356 | PubMed |
| 16 | 10334992 | Identification of a nuclear receptor for bile acids. | Science | 1999 | https://conductscience.org/library/papers/10334992 | PubMed |
| 17 | 18514055 | Upregulation of decorin by FXR in vascular smooth muscle cells. | Biochem Biophys Res Commun | 2008 | https://conductscience.org/library/papers/18514055 | PubMed |
| 18 | 16884925 | Structural correlations in the family of small leucine-rich repeat proteins and proteoglycans. | J Struct Biol | 2006 | https://conductscience.org/library/papers/16884925 | PubMed |
| 19 | 18029909 | Farnesoid x receptor ligands inhibit vascular smooth muscle cell inflammation and migration. | Arterioscler Thromb Vasc Biol | 2007 | https://conductscience.org/library/papers/18029909 | PubMed |
| 20 | 14747391 | Analysis of the relationship between norepinephrine and asymmetric dimethyl arginine levels among patients with end-stage renal disease. | J Am Soc Nephrol | 2004 | https://conductscience.org/library/papers/14747391 | PubMed |
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 78 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42506440 | Mitochondrial Dysfunction in Metabolic-Syndrome-Related MASLD/MASH: Metabolic Mechanisms and Therapeutic Perspectives. | Metabolites | 2026 | https://conductscience.org/library/papers/42506440 | PubMed |
| 40376981 | Farnesoid X receptor‑driven metabolic plasticity: Bridging physiological adaptation and malignant transformation in lipid handling (Review). | Int J Mol Med | 2025 | https://conductscience.org/library/papers/40376981 | PubMed |
| 38887706 | Regulating bile acids signaling for NAFLD: molecular insights and novel therapeutic interventions. | Front Microbiol | 2024 | https://conductscience.org/library/papers/38887706 | PubMed |
| 37815898 | Farnesoid X receptor: From Structure to Function and Its Pharmacology in Liver Fibrosis. | Aging Dis | 2024 | https://conductscience.org/library/papers/37815898 | PubMed |
| 37240434 | Gut Microbiota and Cardiovascular Disease: Evidence on the Metabolic and Inflammatory Background of a Complex Relationship. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37240434 | PubMed |
| 36059946 | Targeted bile acid profiles reveal the liver injury amelioration of Da-Chai-Hu decoction against ANIT- and BDL-induced cholestasis. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36059946 | PubMed |
| 35898963 | Functional, Diagnostic and Therapeutic Aspects of Bile. | Clin Exp Gastroenterol | 2022 | https://conductscience.org/library/papers/35898963 | PubMed |
| 34831429 | The Pathophysiology of Farnesoid X Receptor (FXR) in the GI Tract: Inflammation, Barrier Function and Innate Immunity. | Cells | 2021 | https://conductscience.org/library/papers/34831429 | PubMed |
| 33925648 | In Silico Exploration of the Potential Role of Acetaminophen and Pesticides in the Etiology of Autism Spectrum Disorder. | Toxics | 2021 | https://conductscience.org/library/papers/33925648 | PubMed |
| 33521099 | Overview of bile acid signaling in the cardiovascular system. | World J Clin Cases | 2021 | https://conductscience.org/library/papers/33521099 | PubMed |
| 33462736 | RNA-Seq transcriptome analysis of ileum in Taiping chicken supplemented with the dietary probiotic. | Trop Anim Health Prod | 2021 | https://conductscience.org/library/papers/33462736 | PubMed |
| 33093018 | Effect of Gender and Various Diets on Bile Acid Profile and Related Genes in Mice. | Drug Metab Dispos | 2021 | https://conductscience.org/library/papers/33093018 | PubMed |
| 32846898 | Farnesoid X Receptor Activation Stimulates Organic Cations Transport in Human Renal Proximal Tubular Cells. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32846898 | PubMed |
| 32477430 | Association of serum fibroblast growth factor 19 levels with arteriosclerosis parameters assessed by arterial stiffness and atherogenic index of plasma in patients with type 2 diabetes. | Diabetol Metab Syndr | 2020 | https://conductscience.org/library/papers/32477430 | PubMed |
| 32185502 | Nonalcoholic Fatty Liver Disease. | Handb Exp Pharmacol | 2022 | https://conductscience.org/library/papers/32185502 | PubMed |
| 31783529 | Molecular, Population, and Clinical Aspects of Lipoprotein(a): A Bridge Too Far? | J Clin Med | 2019 | https://conductscience.org/library/papers/31783529 | PubMed |
| 30559664 | Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome. | Front Pharmacol | 2018 | https://conductscience.org/library/papers/30559664 | PubMed |
| 30360466 | Current Therapies Focused on High-Density Lipoproteins Associated with Cardiovascular Disease. | Molecules | 2018 | https://conductscience.org/library/papers/30360466 | PubMed |
| 29452349 | Non-genomic effects of nuclear receptors: insights from the anucleate platelet. | Cardiovasc Res | 2018 | https://conductscience.org/library/papers/29452349 | PubMed |
| 29325602 | Bile Acid Metabolism in Liver Pathobiology. | Gene Expr | 2018 | https://conductscience.org/library/papers/29325602 | PubMed |
Genes48
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20041971
GET https://conductscience.org/api/papers/v1/20041971/references?page=2